DOI QR코드

DOI QR Code

Clinical significance of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in liver transplant recipients

  • Kim, Youn Jeong (Division of Infectious Disease, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • Kim, Sang Il (Division of Infectious Disease, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • Choi, Jong Young (Division of Hepatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • Yoon, Seung Kyu (Division of Hepatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • You, Young-Kyoung (Department of Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea) ;
  • Kim, Dong Goo (Department of Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea)
  • Received : 2014.03.04
  • Accepted : 2014.07.22
  • Published : 2015.09.01

Abstract

Background/Aims: Liver transplant patients are at high risk for methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) colonization. We evaluated patients before and after liver transplant using active surveillance culture (ASC) to assess the prevalence of MRSA and VRE and to determine the effect of bacterial colonization on patient outcome. Methods: We performed ASC on 162 liver transplant recipients at the time of transplantation and 7 days posttransplantation to monitor the prevalence of MRSA and VRE. Results: A total of 142 patients had both nasal and rectal ASCs. Of these patients, MRSA was isolated from 12 (7.4%) at the time of transplantation (group 1a), 9 (6.9%) acquired MRSA posttransplantation (group 2a), and 121 did not test positive for MRSA at either time (group 3a). Among the three groups, group 1a patients had the highest frequency of developing a MRSA infection (p < 0.01); however, group 2a patients had the highest mortality rate associated with MRSA infection (p = 0.05). Of the 142 patients, VRE colonization was detected in 37 patients (22.8%) at the time of transplantation (group 1b), 21 patients (20%) acquired VRE posttransplantation (group 2b), and 84 patients did not test positive for VRE at either time (group 3b). Among these three groups, group 2b patients had the highest frequency of VRE infections (p < 0.01) and mortality (p = 0.04). Conclusions: Patients that acquired VRE or MRSA posttransplantation had higher mortality rates than did those who were colonized pre-transplantation or those who never acquired the pathogens. Our findings highlight the importance of preventing the acquisition of MRSA and VRE posttransplantation to reduce infections and mortality among liver transplant recipients.

Keywords

Acknowledgement

Grant : BK21 플러스 컨버전스 헬스케어 사업단

References

  1. Singh N, Paterson DL, Chang FY, et al. Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis 2000;30:322-327. https://doi.org/10.1086/313658
  2. Kim YJ, Kim SI, Wie SH, et al. Infectious complications in living-donor liver transplant recipients: a 9-year single-center experience. Transpl Infect Dis 2008;10:316-324. https://doi.org/10.1111/j.1399-3062.2008.00315.x
  3. Haddadin AS, Fappiano SA, Lipsett PA. Methicillin resistant Staphylococcus aureus (MRSA) in the intensive care unit. Postgrad Med J 2002;78:385-392. https://doi.org/10.1136/pmj.78.921.385
  4. Niven DJ, Laupland KB, Gregson DB, Church DL; S aureus Screening Initiative Group. Epidemiology of Staphylococcus aureus nasal colonization and influence on outcome in the critically ill. J Crit Care 2009;24:583-589. https://doi.org/10.1016/j.jcrc.2008.10.004
  5. Kim YJ, Kim SI, Kim YR, Lee JY, Park YJ, Kang MW. Risk factors for vancomycin-resistant enterococci infection and mortality in colonized patients on intensive care unit admission. Am J Infect Control 2012;40:1018-1019. https://doi.org/10.1016/j.ajic.2012.01.009
  6. Weinstock DM, Conlon M, Iovino C, et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007;13:615-621. https://doi.org/10.1016/j.bbmt.2007.01.078
  7. Chang FY, Singh N, Gayowski T, Drenning SD, Wagener MM, Marino IR. Staphylococcus aureus nasal colonization and association with infections in liver transplant recipients. Transplantation 1998;65:1169-1172. https://doi.org/10.1097/00007890-199805150-00004
  8. Desai D, Desai N, Nightingale P, Elliott T, Neuberger J. Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation. Liver Transpl 2003;9:754-759. https://doi.org/10.1053/jlts.2003.50142
  9. Russell DL, Flood A, Zaroda TE, et al. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant 2008;8:1737-1743. https://doi.org/10.1111/j.1600-6143.2008.02304.x
  10. Hashimoto M, Sugawara Y, Tamura S, et al. Acquisition of methicillin-resistant Staphylococcus aureus after living donor liver transplantation: a retrospective cohort study. BMC Infect Dis 2008;8:155. https://doi.org/10.1186/1471-2334-8-155
  11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-140. https://doi.org/10.1016/0196-6553(88)90053-3
  12. Willey BM, Jones RN, McGeer A, et al. Practical approach to the identification of clinically relevant Enterococcus species. Diagn Microbiol Infect Dis 1999;34:165-171. https://doi.org/10.1016/S0732-8893(99)00032-2
  13. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S18. Wayne: Clinical and Laboratory Standards Institute, 2009.
  14. Seo JY, Kim PW, Lee JH, et al. Evaluation of PCR-based screening for vancomycin-resistant enterococci com-pared with a chromogenic agar-based culture method. J Med Microbiol 2011;60(Pt 7):945-949. https://doi.org/10.1099/jmm.0.029777-0
  15. McNeil SA, Malani PN, Chenoweth CE, et al. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis 2006;42:195-203. https://doi.org/10.1086/498903
  16. Woeste G, Zapletal C, Wullstein C, Golling M, Bechstein WO. Influence of methicillin-resistant Staphylococcus aureus carrier status in liver transplant recipients. Transplant Proc 2005;37:1710-1712. https://doi.org/10.1016/j.transproceed.2005.03.136
  17. Santoro-Lopes G, de Gouvea EF, Monteiro RC, et al. Colonization with methicillin-resistant Staphylococcus aureus after liver transplantation. Liver Transpl 2005;11:203-209. https://doi.org/10.1002/lt.20338
  18. Polisena J, Chen S, Cimon K, McGill S, Forward K, Gardam M. Clinical effectiveness of rapid tests for methicillin resistant Staphylococcus aureus (MRSA) in hospitalized patients: a systematic review. BMC Infect Dis 2011;11:336. https://doi.org/10.1186/1471-2334-11-336
  19. Bert F, Bellier C, Lassel L, et al. Risk factors for Staphylococcus aureus infection in liver transplant recipients. Liver Transpl 2005;11:1093-1099. https://doi.org/10.1002/lt.20491
  20. Marshall C, Harrington G, Wolfe R, Fairley CK, Wesselingh S, Spelman D. Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol 2003;24:322-326. https://doi.org/10.1086/502215
  21. Asensio A, Guerrero A, Quereda C, Lizan M, Martinez-Ferrer M. Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol 1996;17:20-28. https://doi.org/10.2307/30142361

Cited by

  1. Infection Prevention in Transplantation vol.18, pp.2, 2016, https://doi.org/10.1007/s11908-015-0513-6
  2. Virulence and resistance profiles of MRSA isolates in pre- and post-liver transplantation patients using microarray vol.65, pp.10, 2015, https://doi.org/10.1099/jmm.0.000324
  3. Predictors of postoperative infectious complications in liver transplant recipients: experience of 185 consecutive cases vol.33, pp.4, 2015, https://doi.org/10.3904/kjim.2017.230
  4. Methicillin-resistant Staphylococcus aureus bacteremia among liver transplant recipients: epidemiology and associated risk factors for morbidity and mortality vol.11, pp.None, 2018, https://doi.org/10.2147/idr.s161180
  5. Hygienemaßnahmen zur Prävention der Infektion durch Enterokokken mit speziellen Antibiotikaresistenzen : Empfehlung der Kommission für Krankenhaushygiene und Infektionsprävention (KRIN vol.61, pp.10, 2015, https://doi.org/10.1007/s00103-018-2811-2
  6. Factors Associated with Vancomycin-Resistant Enterococcus Colonization in Patients Transferred to Emergency Departments in Korea vol.33, pp.48, 2015, https://doi.org/10.3346/jkms.2018.33.e295
  7. The direct and indirect effects of vancomycin-resistant enterococci colonization in liver transplant candidates and recipients vol.17, pp.5, 2019, https://doi.org/10.1080/14787210.2019.1607297
  8. Vancomycin‐resistant Enterococcus in solid organ transplant recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice vol.33, pp.9, 2015, https://doi.org/10.1111/ctr.13549
  9. Transplantation of a kidney from a donor with vancomycin-resistantEnterococci vol.34, pp.2, 2020, https://doi.org/10.4285/kjt.2020.34.2.114
  10. Clinical Outcome of Vancomycin-Resistant Enterococcus Colonization Among Liver Transplant Recipients at Shiraz Organ Transplant Center vol.19, pp.8, 2015, https://doi.org/10.6002/ect.2020.0443
  11. Reduced pannexin 1–IL-33 axis function in donor livers increases risk of MRSA infection in liver transplant recipients vol.13, pp.606, 2015, https://doi.org/10.1126/scitranslmed.aaz6169